News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Agenus (AGEN Roche (ROCHE) NANTKWEST (NK) OSI (OSIP) Theravance (THRX) Sangamo (SGMO) ZALTRAP™ Regeneron (REGN) Human Genome Sciences (HGSI) NEKTAR (NKTR)) ISIS (ISIS) Incyte (INCY) Ziofpharm (ZIOP) Biogen Idec (BIIB) SUNESIS PHARMACEUTICALS (SNSS) Vertex (VRTX) ABBVIE (ABBV) Merck (MRK) Idenix (IDIX) Prolor Biotech (PBTH) Rapamune Alnylam (ALNY) Sanofi-Aventis (SAN) BIOMARIN (BMRN) Ridaforolimus Dynavax (DVAX) SERES THERAPEUTICS (MCRB) Elan (ELN) Dendreon (DNDN) Biocryst (BCRX) Endometrial Cancer Pluristem (PSTI) Mirati Therapeutics (MRTX) SYNTA (SNTA) Xoma (XOMA) Trastuzumab-DM1 GUARDIAN HEALTH Herceptin Genentech Galena (GALE) Onyx (ONXX) KITE (KITE) Intermune (ITMN) Amgen (AMGN) Roche (RHHBY) Intercept (ICPT) Multiple Myeloma Revlimid (lenolidamide) Micromet (MITI) Auspex (ASPX) CompuGen (CGEN) Sanofi (SNY) Anacor (ANAC) Zerenex Sequenom (SQNM) Prosensa (RNA) Exelixis (EXEL) KERYX (KERX) Telaprevir Intrexon (XON) Array Pharmaceuticals (ARRY) galapagos (GLPG) ARCA (ABIO) Seattle Genetics (SGEN) AERIE PHARMACEUTICALS Tysabri Abbott Laboratories (ABT) Bristol-Myers Squibb (BMY) Benlysta (belimumab) Ariad (ARIA) Agenus (AGEN) Velcade (bortezomib) GlaxoSmithKline (GSK) IDERA (IDRA) ADVENTRIX (ANX) TOKAI (TKAOI) JUNO (JUNO) Sanofi (SNA) HALOZYME (HALO) Aimmune Therapeutics (AIMT) Sarepta (SRPT) ImmunoGen (IMGN) VANDA (VNDA) Inovio (INO) Gilead (GILD) Valeant Pharmaceuticals International (VRX) Cytokinetics (CYTK) Illumina (ILMN) Jazz Pharmaceuticals (JAZZ) Anadys (ANDS) C4 Therapeutics